FLEXION THERAPEUTICS INC - NOTE 3.375% 5/0

CUSIP: 33938JAB2

Q4 2021 13F Holders as of 31 Dec 2021

Type / Class
Debt / NOTE 3.375% 5/0
Market price (% of par)
100.26%
Total 13F principal
$68,506,000
Principal change
-$59,294,000
Total reported market value
$71,019,966
Number of holders
8
Value change
-$45,848,181
Number of buys
6
Number of sells
25

Quarterly Holders Quick Answers

What is CUSIP 33938JAB2?
CUSIP 33938JAB2 identifies 33938JAB2 - FLEXION THERAPEUTICS INC - NOTE 3.375% 5/0 in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of FLEXION THERAPEUTICS INC - NOTE 3.375% 5/0 as of Q4 2021

As of 31 Dec 2021, FLEXION THERAPEUTICS INC - NOTE 3.375% 5/0 was held by 8 institutional bondholders reporting positions in Form 13F filings. These institutions reported holding $68,506,000 in principal (par value) of the bond. The largest 8 bondholders included GLAZER CAPITAL, LLC, TENOR CAPITAL MANAGEMENT Co., L.P., Cohanzick Management, LLC, Verition Fund Management LLC, Mint Tower Capital Management B.V., CALAMOS ADVISORS LLC, MERCER GLOBAL ADVISORS INC /ADV, and WEDBUSH SECURITIES INC. This page lists 8 institutional bondholders reporting positions for the Q4 2021 filing period.
Investor Option Weight % Change % Value $ * Price (% of par) Principal Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.